메뉴 건너뛰기




Volumn 18, Issue SUPPL.4, 2012, Pages 131-135

Personalized prophylaxis

Author keywords

Arthropathy; Haemarthrosis; Haemophilia; Pharmacokinetics; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

EID: 84862872608     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02838.x     Document Type: Article
Times cited : (83)

References (26)
  • 1
    • 0028004222 scopus 로고
    • A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group
    • Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391-9.
    • (1994) J Intern Med , vol.236 , pp. 391-399
    • Aledort, L.M.1    Haschmeyer, R.H.2    Pettersson, H.3
  • 2
    • 0033028402 scopus 로고    scopus 로고
    • Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized
    • Astermark J, Petrini P, Tengborn L, Schulman S, Ljung R, Berntorp E. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105: 1109-13.
    • (1999) Br J Haematol , vol.105 , pp. 1109-1113
    • Astermark, J.1    Petrini, P.2    Tengborn, L.3    Schulman, S.4    Ljung, R.5    Berntorp, E.6
  • 3
    • 0036529818 scopus 로고    scopus 로고
    • The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia
    • Fischer K, van der Bom JG, Mauser-Bunschoten EP et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002; 99: 2337-41.
    • (2002) Blood , vol.99 , pp. 2337-2341
    • Fischer, K.1    van der Bom, J.G.2    Mauser-Bunschoten, E.P.3
  • 4
    • 34547757915 scopus 로고    scopus 로고
    • Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
    • Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
    • (2007) N Engl J Med , vol.357 , pp. 535-544
    • Manco-Johnson, M.J.1    Abshire, T.C.2    Shapiro, A.D.3
  • 6
    • 0026635406 scopus 로고
    • Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B
    • Nilsson IM, Berntorp E, Lofquist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
    • (1992) J Intern Med , vol.232 , pp. 25-32
    • Nilsson, I.M.1    Berntorp, E.2    Lofquist, T.3    Pettersson, H.4
  • 7
    • 77951681450 scopus 로고    scopus 로고
    • A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A
    • Richards M, Williams M, Chalmers E et al. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A. Br J Haematol 2010; 149: 498-507.
    • (2010) Br J Haematol , vol.149 , pp. 498-507
    • Richards, M.1    Williams, M.2    Chalmers, E.3
  • 8
    • 0013836217 scopus 로고
    • Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B
    • Ahlberg A. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand Suppl 1965; Suppl. 77: 3-132.
    • (1965) Acta Orthop Scand Suppl , Issue.SUPPL. 77 , pp. 3-132
    • Ahlberg, A.1
  • 9
    • 0027324261 scopus 로고
    • Experience with prophylaxis in Sweden
    • Nilsson IM. Experience with prophylaxis in Sweden. Semin Hematol 1993; 30: 16-9.
    • (1993) Semin Hematol , vol.30 , pp. 16-19
    • Nilsson, I.M.1
  • 10
    • 0036827020 scopus 로고    scopus 로고
    • Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen
    • Fischer K, Astermark J, van der Bom JG et al. Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen. Haemophilia 2002; 8: 753-60.
    • (2002) Haemophilia , vol.8 , pp. 753-760
    • Fischer, K.1    Astermark, J.2    van der Bom, J.G.3
  • 11
    • 59849093369 scopus 로고    scopus 로고
    • Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
    • Collins PW, Blanchette VS, Fischer K et al. Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A. J Thromb Haemost 2009; 7: 413-20.
    • (2009) J Thromb Haemost , vol.7 , pp. 413-420
    • Collins, P.W.1    Blanchette, V.S.2    Fischer, K.3
  • 12
    • 34548180049 scopus 로고    scopus 로고
    • Measurement of global haemostasis in severe haemophilia A following factor VIII infusion
    • Lewis SJ, Stephens E, Florou G et al. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion. Br J Haematol 2007; 138: 775-82.
    • (2007) Br J Haematol , vol.138 , pp. 775-782
    • Lewis, S.J.1    Stephens, E.2    Florou, G.3
  • 13
    • 84857951468 scopus 로고    scopus 로고
    • Clinical severity of haemophilia A: does the classification of the 1950s still stand?
    • Den Uijl IEM, Mauser Bunschoten EP, Roosendaal G et al. Clinical severity of haemophilia A: does the classification of the 1950s still stand? Haemophilia 2011; 17: 849-53.
    • (2011) Haemophilia , vol.17 , pp. 849-853
    • Den Uijl, I.E.M.1    Mauser Bunschoten, E.P.2    Roosendaal, G.3
  • 14
    • 79951472629 scopus 로고    scopus 로고
    • Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
    • Collins PW, Fischer K, Morfini M, Blanchette VS, Bjorkman S. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia 2011; 17: 2-10.
    • (2011) Haemophilia , vol.17 , pp. 2-10
    • Collins, P.W.1    Fischer, K.2    Morfini, M.3    Blanchette, V.S.4    Bjorkman, S.5
  • 15
    • 77954851703 scopus 로고    scopus 로고
    • Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A
    • Bjorkman S. Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A. Haemophilia 2010; 16: 597-605.
    • (2010) Haemophilia , vol.16 , pp. 597-605
    • Bjorkman, S.1
  • 16
    • 79951902782 scopus 로고    scopus 로고
    • Evaluation of the TCIWorks Bayesian computer program for estimation of individual pharmacokinetics of FVIII
    • Bjorkman S. Evaluation of the TCIWorks Bayesian computer program for estimation of individual pharmacokinetics of FVIII. Haemophilia 2011; 17: e239-e340.
    • (2011) Haemophilia , vol.17
    • Bjorkman, S.1
  • 17
    • 84855853759 scopus 로고    scopus 로고
    • Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight
    • Bjorkman S, Oh M, Spotts G et al. Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight. Blood 2012; 119: 612-8.
    • (2012) Blood , vol.119 , pp. 612-618
    • Bjorkman, S.1    Oh, M.2    Spotts, G.3
  • 18
    • 74749088081 scopus 로고    scopus 로고
    • Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens
    • Collins PW, Bjorkman S, Fischer K et al. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens. J Thromb Haemost 2010; 8: 269-75.
    • (2010) J Thromb Haemost , vol.8 , pp. 269-275
    • Collins, P.W.1    Bjorkman, S.2    Fischer, K.3
  • 19
    • 77952712296 scopus 로고    scopus 로고
    • Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring
    • Bjorkman S, Blanchette VS, Fischer K et al. Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring. J Thromb Haemost 2010; 8: 730-6.
    • (2010) J Thromb Haemost , vol.8 , pp. 730-736
    • Bjorkman, S.1    Blanchette, V.S.2    Fischer, K.3
  • 20
    • 73049092113 scopus 로고    scopus 로고
    • Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study
    • Collins P, Faradji A, Morfini M, Enriquez MM, Schwartz L. Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study. J Thromb Haemost 2010; 8: 83-9.
    • (2010) J Thromb Haemost , vol.8 , pp. 83-89
    • Collins, P.1    Faradji, A.2    Morfini, M.3    Enriquez, M.M.4    Schwartz, L.5
  • 21
    • 0035106558 scopus 로고    scopus 로고
    • Long-term outcome of individualized prophylactic treatment of children with severe haemophilia
    • van den Berg HM, Fischer K, Mauser-Bunschoten EP et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol 2001; 112: 561-5.
    • (2001) Br J Haematol , vol.112 , pp. 561-565
    • van den Berg, H.M.1    Fischer, K.2    Mauser-Bunschoten, E.P.3
  • 22
    • 0001776145 scopus 로고    scopus 로고
    • Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis
    • Carlsson M, Bjorkman S, Berntorp E. Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis. Haemophilia 1998; 4: 83-8.
    • (1998) Haemophilia , vol.4 , pp. 83-88
    • Carlsson, M.1    Bjorkman, S.2    Berntorp, E.3
  • 23
    • 0030940593 scopus 로고    scopus 로고
    • Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
    • Carlsson M, Berntorp E., Bjorkman S., Lethergen S, Ljung R. Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A. Haemophilia 1997; 3: 96-101.
    • (1997) Haemophilia , vol.3 , pp. 96-101
    • Carlsson, M.1    Berntorp, E.2    Bjorkman, S.3    Lethergen, S.4    Ljung, R.5
  • 24
    • 0035543814 scopus 로고    scopus 로고
    • Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome
    • Fischer K, van der Bom JG, Prejs R et al. Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome. Haemophilia 2001; 7: 444-50.
    • (2001) Haemophilia , vol.7 , pp. 444-450
    • Fischer, K.1    van der Bom, J.G.2    Prejs, R.3
  • 25
    • 11044225204 scopus 로고    scopus 로고
    • The impact of information technology on haemophilia care
    • Baker RI, Laurenson L, Winter M, Pritchard AM. The impact of information technology on haemophilia care. Haemophilia 2004; 10(Suppl. 4): 41-6.
    • (2004) Haemophilia , vol.10 , Issue.SUPPL. 4 , pp. 41-46
    • Baker, R.I.1    Laurenson, L.2    Winter, M.3    Pritchard, A.M.4
  • 26
    • 0038441404 scopus 로고    scopus 로고
    • Pilot study of an Internet-based electronic patient treatment record and communication system for haemophilia, Advoy.com
    • Collins PW, Bolton-Maggs P, Stephenson D, Jenkins B, Loran C, Winter M. Pilot study of an Internet-based electronic patient treatment record and communication system for haemophilia, Advoy.com. Haemophilia 2003; 9: 285-91.
    • (2003) Haemophilia , vol.9 , pp. 285-291
    • Collins, P.W.1    Bolton-Maggs, P.2    Stephenson, D.3    Jenkins, B.4    Loran, C.5    Winter, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.